Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity

H. G. Keizer; H. M. Pinedo; G. J. Schuurhuis; H. Joenje

doi:10.1016/0163-7258(90)90088-J

Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity

H. G. Keizer, H. M. Pinedo, G. J. Schuurhuis, H. Joenje

Research output: Contribution to journal › Article

Abstract

The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered critical for its antitumor action. However, for most tumor cell lines this mechanism of cytotoxicity does not appear to play a major role. Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.

Original language	English (US)
Pages (from-to)	219-231
Number of pages	13
Journal	Pharmacology and Therapeutics
Volume	47
Issue number	2
DOIs	https://doi.org/10.1016/0163-7258(90)90088-J
State	Published - 1990
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Pharmacology

Cite this

Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990). Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacology and Therapeutics, 47(2), 219-231. https://doi.org/10.1016/0163-7258(90)90088-J

@article{51510e9c94d247409e0df2dc83883900,

title = "Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity",

abstract = "The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered critical for its antitumor action. However, for most tumor cell lines this mechanism of cytotoxicity does not appear to play a major role. Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.",

author = "Keizer, {H. G.} and Pinedo, {H. M.} and Schuurhuis, {G. J.} and H. Joenje",

year = "1990",

doi = "10.1016/0163-7258(90)90088-J",

language = "English (US)",

volume = "47",

pages = "219--231",

journal = "Pharmacology and Therapeutics",

issn = "0163-7258",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Doxorubicin (adriamycin)

T2 - A critical review of free radical-dependent mechanisms of cytotoxicity

AU - Keizer, H. G.

AU - Pinedo, H. M.

AU - Schuurhuis, G. J.

AU - Joenje, H.

PY - 1990

Y1 - 1990

N2 - The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered critical for its antitumor action. However, for most tumor cell lines this mechanism of cytotoxicity does not appear to play a major role. Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.

AB - The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered critical for its antitumor action. However, for most tumor cell lines this mechanism of cytotoxicity does not appear to play a major role. Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.

UR - http://www.scopus.com/inward/record.url?scp=0025283897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025283897&partnerID=8YFLogxK

U2 - 10.1016/0163-7258(90)90088-J

DO - 10.1016/0163-7258(90)90088-J

M3 - Article

C2 - 2203071

AN - SCOPUS:0025283897

VL - 47

SP - 219

EP - 231

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -

Access to Document

10.1016/0163-7258(90)90088-J